Lung cancer
12 articles shown
When the fluid on your chest is 'too thick to drain with a needle' — understanding loculated pleural effusion and why a referral to a larger hospital happens
When water on the chest (pleural effusion) is thick or divided into pockets, a simple needle tap may not drain it well. This piece explains why loculated effusions form, alternatives such as image-guided catheters, chest tubes and fibrinolytics, and why a transfer to a hospital with the right equipment and specialists is sometimes advised.
When a Lung Nodule Grows a Little and Surgery Is Advised — but 'It Might Turn Out to Be Inflammation'
Being told a slightly enlarged lung nodule needs surgery while it 'might be inflammation' is confusing. This piece explains the many causes of lung nodules, why a PET-CT's SUV value can rise even in inflammation, why benign lesions can also change size, and why surgery on an indeterminate nodule serves as both diagnosis and treatment — offering a steadier way to sit with the wait for results.
When Lung Surgery Is Advised Before Cancer Is Confirmed — Understanding Diagnostic Resection and Intraoperative Frozen-Section Biopsy
This article addresses being advised to have a suspicious lung lesion surgically removed—rather than needle-biopsied first—because it is large or has not shrunk. It explains why needle biopsy of lung lesions can be difficult, the reasoning behind diagnostic resection, how an intraoperative frozen-section biopsy allows diagnosis and treatment in a single operation, and that a second opinion at a major center is possible even before a diagnosis is confirmed.
When Lung Spots Are Watched for Years Instead of Biopsied — Understanding Surveillance of Indeterminate Pulmonary Nodules
Explains why suspicious small lung nodules are often watched over time instead of biopsied, why growth rate helps tell metastasis from benign spots, why small nodules are risky to biopsy, and how to cope with the long uncertainty.
Never Smoked, Yet Lung Cancer Is Suspected — Why Doctors Always Ask About Smoking, and Understanding Lung Cancer in Non-Smokers
Being asked about smoking when you never smoked can feel unfair. This piece explains why the question is routine, why non-smokers can still develop lung cancer, and why genetic testing and targeted therapy matter.
When targeted therapy starts to stop working, why do they suggest another biopsy?
When resistance to lung cancer targeted therapy develops, a repeat biopsy is recommended to find out how the cancer is evading the drug. A new mutation such as T790M or a change in tissue type can determine the next treatment choice, and when a tissue biopsy feels burdensome, a liquid biopsy done with blood can be an alternative.
When Lung Cancer Spreads to the Brain: The Treatments You Can Choose Now
Because of how blood flows, lung cancer readily spreads to the brain, and it is nothing to blame yourself for. Depending on the number, location, and size of the metastases and the patient condition, treatment may go toward stereotactic radiosurgery, whole-brain radiation therapy, surgery, or drugs such as EGFR and ALK targeted therapies and immunotherapy. Because genetic testing reveals the nature of the tumor and widens the options, it is best to ask your doctor directly whether targeted or immune therapy is possible for you.
Stereotactic Body Radiation Therapy (SBRT) for Lung Cancer: Another Path When Surgery Is Not an Option
SBRT (stereotactic body radiation therapy) delivers a high dose of radiation precisely to a lung tumor in just 3 to 8 sessions. For early-stage lung cancer patients who cannot undergo surgery, it offers an outpatient alternative with quick recovery, though it carries risks such as radiation pneumonitis and requires careful follow-up. The decision depends on tumor size, location, and lung function, and should be made together with your doctor.
Bone Metastasis from Lung Cancer: Treatments That Tame Pain and Fractures
Lung cancer spreads readily to bone, often causing pain or fractures in the spine, pelvis, and ribs. Radiation therapy calms painful sites, while bone-protecting drugs such as zoledronic acid and denosumab reduce fractures and high blood calcium. Pain medication, surgical fixation, and targeted or immune therapy are combined, with the goal of preserving quality of life.
Lung Cancer Staging: What the Numbers Tell You, and What Comes Next in Treatment
Lung cancer staging combines tumor size (T), lymph node involvement (N), and metastasis (M) into stages 1 through 4 — a kind of map of where the cancer stands inside your body. Even at the same stage, the details and the type of cancer (non-small cell vs. small cell) steer treatment toward surgery, radiation, or drug therapy, and the stage itself can be reassessed as treatment progresses.
Lung Cancer Without Ever Smoking? Causes and Testing for Non-Smokers
Lung cancer can develop even if you've never smoked. Environmental factors like secondhand smoke, radon, and occupational exposure, along with gene mutations such as EGFR and ALK, are the main culprits, and early on there are almost no symptoms. It's confirmed with low-dose chest CT and tissue and genetic testing, and if you have risk factors, it's wise to discuss screening timing with your doctor in advance.
Starting immunotherapy for lung cancer (immune checkpoint inhibitors): what's worth knowing first
A patient-friendly rundown of how immune checkpoint inhibitors for lung cancer work, why PD-L1 and genetic testing matters before treatment, and what to expect from immune-related side effects and the phenomenon of pseudoprogression.